Emotional Regulation in Patients With Implanted Automatic Defibrillator

Efficacy of Mindfulness Training on the Quality of Life of Patients With Implantable Automatic Defibrillator

The general objective of the study was to evaluate the impact of two emotional regulation programs, one standardized and face-to-face (MBSR: Mindfulness Based Stress Reduction) and, another, implemented through a mobile phone application (REM_Volver a casa; ERBM_Back home: Emotional Regulation Based on Mindfulness), on the quality of life, the state emotional and psychological and biological variables associated with stress, in a sample of patients with ICD (implantable cardioverter defibrillator).

The working hypotheses were that after training in emotional regulation, patients with ICD would have better quality of life, lower symptoms of anxiety, depression and hostility, and lower incidence of ventricular arrhythmias than patients in the control group, as well as that there would be no differences between the two tools used for training.

Study Overview

Detailed Description

The recruitment process of the participants was carried out by telephone, by the medical staff of the arrhythmia's section, who informed the patients the characteristics and objectives of the study.

The sample size was estimated considering an alpha risk of 0.05 and a beta risk of 0.2, in a bilateral contrast, to detect a difference equal to or greater than 10 units in the Quality of life variable. A standard deviation of 20 points and a 20% loss rate were assumed. The estimated n was 237 patients, to distribute in three branches of 79 patients each.

Before beginning the intervention, participants were informed about the research, and were offered the opportunity to ask questions in order to clarify any doubts about it. Next, they were given a Participant Data Collection Notebook. The Notebook included the information on the investigation and the Informed Consent, to be completed and signed; the request for demographic data (age, gender, educational level, etc.); and, the four questionnaires used to assess the psychological variables of study: SF-36 (quality of life), HADS (anxiety and depression), STAXI (hostility) and FFMQ (Mindfulness) For the descriptive analysis, the number of subjects and the corresponding percentage was used in the qualitative variables. In the quantitative variables the mean and standard deviation were used when the variables adjusted to the normal distribution; otherwise, the median and interquartile range (first and third quartile) were used. The normality test used was the Shapiro-Wilk.

In the hypothesis contrast of the pre-post values, of the variables with distribution adjusted to normal, the Student´s t statistic was used for paired data; For the variables whose distribution did not conform to normal, the Wilcoxon Test was chosen.

For the contrast of inter-group hypothesis (independent samples with distribution not adjusted to normal), the Mann Whitney test was used.

For the statistical analysis of data, the SPSS program, version 20, was used.

Study Type

Interventional

Enrollment (Actual)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28046
        • La Paz University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age equal to or greater than 18 years.
  • Be a patient of the University Hospital La Paz and have an ICD implanted whose implant was equal to or greater than three months.
  • Sufficient knowledge of the Spanish language.
  • Have a mobile phone and the ability to handle applications on the phone.
  • Availability and sufficient physical conditions to attend mindfulness training in the face-to-face format.

Exclusion Criteria:

  • Be over 75 years old.
  • Be waiting for a heart transplant or other operation related to cardiac pathology.
  • Have previous training in mindfulness, unless it had been done before 5 years and had not been practiced since then.
  • Being diagnosed with a serious mental disorder and being in an acute symptomatic period of the disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Usual care
Experimental: MBSR group
Enforcement of the standardized program Mindfulness-Based Stress Reduction
Mindfulness training through an adaptation of the standardized MBSR program. This program was conducted in person and in a group, with a maximum of 25 participants per group and a total duration of 8 weeks. The training was carried out in 8 sessions, one each week, with a duration of 2 h each session.
Experimental: App group.
Enforcement of the emotional regulation program based on mindfulness (ERM) through the mobile phone application REM volver a casa
The intervention was carried out through the computer application for mobile phone "REM volver a casa". This application has been developed to carry out training in the emotional regulation program based on mindfulness, autonomously. The application is designed to carry out the program in 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health Related Quality of Life
Time Frame: In order to assess the change at the Quality of life variable, was measured just before starting the mindfulness training program and, eight weeks later, after finishing it.
The questionnaire (SF-36: Short Form) uses a Likert scale of 3 or 5 points, with a range of scores from 0 to 100, average of 50 and standard deviation 10.
In order to assess the change at the Quality of life variable, was measured just before starting the mindfulness training program and, eight weeks later, after finishing it.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety and Depression
Time Frame: In order to assess the change at the anxiety and depression variables, were measured just before starting the mindfulness training program and, eight weeks later, after finishing it.
HADS: Hospital Anxiety and Depression Scale. This scale assess the presence of anxiety or depression. It consists of two sub-scales, of 7 items each, are scored on a Likert scale of 4 points. The cut-off points used for the two scales were: 0 to 7 = no clinical significance; from 8 to 10 = doubtful; from 11 to 14 = moderate; from 15 to 21 = severe.
In order to assess the change at the anxiety and depression variables, were measured just before starting the mindfulness training program and, eight weeks later, after finishing it.
Anger
Time Frame: In order to assess the change at the Anger variable, was measured just before starting the mindfulness training program and, eight weeks later, after finishing it.
STAXI: State-Trait Anger Expression Inventory. Questionnaire used to evaluate the expression of hostility, in terms of personality trait and regarding the circumstantial state at the time of measurement. The scores are represented in standardized T scores: mean of 50 points and a standard deviation of 10 points.
In order to assess the change at the Anger variable, was measured just before starting the mindfulness training program and, eight weeks later, after finishing it.
AHR
Time Frame: To assess the change in the AHR variable, the data collected corresponded to the two months before the intervention and the two months after the intervention.
Average Heart Rate (AHR).These parameters were obtained from the data record of the defibrillator implanted in each patient, and is quantified by beats per minute.
To assess the change in the AHR variable, the data collected corresponded to the two months before the intervention and the two months after the intervention.
NSVT
Time Frame: To assess the change in the NSVT variable, the data collected corresponded to the two months before the intervention and the two months after the intervention.
Number of Non-Sustained Ventricular Tachycardia (NSVT). These parameters were obtained from the data record of the defibrillator implanted in each patient, and is quantified by whole numbers.
To assess the change in the NSVT variable, the data collected corresponded to the two months before the intervention and the two months after the intervention.
LVEF
Time Frame: The value of this parameter is recorded at the beginning of the study.

Left Ventricular Ejection Fraction (LVEF). The ejection fraction is the force with which the left ventricle contracts and is related to the patient's prognosis and its symptomatology. This parameter is classified into four levels, according to the percentage.

  1. Less than 40%: heart failure.
  2. From 40 to 55%: below normal heart function.
  3. From 55 to 70%: normal heart function.
  4. Higher than 75%: can indicate a heart condition.
The value of this parameter is recorded at the beginning of the study.
FC
Time Frame: The value of this parameter is recorded at the beginning of the study.

Functional Class (FC). The functional class for dyspnea is a classification according to the degree to which patients have the feeling of shortness of breath. The functional classification is determined according to the following four levels:

  1. Without any limitation of physical activity.
  2. Slight limitation of physical activity.
  3. Marked limitation of physical activity.
  4. Inability to carry out any physical activity without symptoms.
The value of this parameter is recorded at the beginning of the study.
Number of Shocks
Time Frame: The estimated period of evaluation is up to 8 years. The events (shocks) accounted are for the period between the date of implantation of the device and the date of the last data collection, approximately 33 months after the start of the study.
Number of shocks produced by the implantable automatic defibrillator, in each patient. Events (shocks) are determined by their registration in the device (implantable automatic defibrillator). The device has a record in which it stores parameters related to the functioning of the heart and the regulation and control processes performed by the device, among them, the shocks it gives in order to restore a situation of ventricular fibrillation or ventricular arrhythmia. This parameter is quantified by whole numbers.
The estimated period of evaluation is up to 8 years. The events (shocks) accounted are for the period between the date of implantation of the device and the date of the last data collection, approximately 33 months after the start of the study.
Daily Activity
Time Frame: To assess the change in the Daily Activity variable, the data collected corresponded to the two months before the intervention and the two months after the intervention.
Number of daily hours of activity, recorded by the implantable automatic defibrillator device. This parameter is quantified in hours.
To assess the change in the Daily Activity variable, the data collected corresponded to the two months before the intervention and the two months after the intervention.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mindfulness attitude
Time Frame: The data corresponding to the mindfulness attitude measured just before starting the mindfulness training program and, eight weeks later, after finishing it.
FFMQ: Five Facet Mindfulness Questionnaire. In this questionnaire five factors of mindfulness ability are collected: Observe, from 8 to 40 points; Describe, from 8 to 40 points; Act consciously, from 8 to 40 points; Not judge, from 8 to 40 points; and, Not react, from 7 to 35 points.
The data corresponding to the mindfulness attitude measured just before starting the mindfulness training program and, eight weeks later, after finishing it.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Beatriz Rodríguez Vega, Doctor, La Paz University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2017

Primary Completion (Actual)

February 15, 2017

Study Completion (Actual)

May 30, 2018

Study Registration Dates

First Submitted

November 29, 2019

First Submitted That Met QC Criteria

January 18, 2020

First Posted (Actual)

January 22, 2020

Study Record Updates

Last Update Posted (Actual)

January 22, 2020

Last Update Submitted That Met QC Criteria

January 18, 2020

Last Verified

November 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ventricular Fibrillation

Clinical Trials on Mindfulness-based stress reduction program

Subscribe